Literature DB >> 5855885

Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man.

J H Peters, K S Miller, P Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5855885

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  25 in total

1.  Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.

Authors:  H G Boxenbaum; I Berkersky; V Mattaliano; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  Pharmacokinetics of isoniazid metabolism in man.

Authors:  G A Ellard; P T Gammon
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

4.  The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.

Authors:  E C Johnstone
Journal:  Psychopharmacologia       Date:  1976-04-15

5.  Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosis.

Authors:  L Eidus; P Varughese; M M Hodgkin; A H Hsu; K B McRae
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

6.  The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man.

Authors:  H G Boxenbaum; G S Jodhka; A C Ferguson; S Riegelman; T R MacGregor
Journal:  J Pharmacokinet Biopharm       Date:  1974-06

7.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

8.  Inactivation of isoniazid by Canadian Eskimos and Indians.

Authors:  C W Jeanes; O Schaefer; L Eidus
Journal:  Can Med Assoc J       Date:  1972-02-19       Impact factor: 8.262

9.  Lymphocyte-mediated cytotoxicity in isoniazid-associated hepatitis.

Authors:  R J Warrington; S L Olivier
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

10.  An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.

Authors:  G A Ellard; P J Jenner; P A Downs
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.